Janusz Jaśkiewicz

Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors

Lars Holmberg, Ole Erik Iversen, C.-M. Rudenstam et al. · JNCI Journal of the National Cancer Institute · 2008 · 335 citations · Full text

Preoperative nutritional support in cancer patients with no clinical signs of malnutrition—prospective randomized controlled trial

Paweł Kabata, T Jastrzebski, Michał Kąkol et al. · Supportive Care in Cancer · 2014 · 140 citations · Full text

Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a Phase I multicentre trial in patients scheduled for elective breast cancer surgery

Nigel Bundred, Jānis Gardovskis, Janusz Jaśkiewicz et al. · Investigational New Drugs · 2013 · 88 citations

Parp Inhibitor Olaparib, Surgical Oncology, Breast Oncology +9

Prognostic value of 5-microRNA based signature in T2-T3N0 colon cancer

Maciej Bobowicz, Marcin Skrzypski, Piotr Czapiewski et al. · Clinical & Experimental Metastasis · 2016 · 75 citations · Full text

Surgical Oncology, Engineering, Immunology +16

Analysis of selected factors influencing seroma formation in breast cancer patients undergoing mastectomy

Jacek Zieliński, Radosław Jaworski, Ninela Irga‐Jaworska et al. · Archives of Medical Science · 2012 · 65 citations · Full text